Baird Financial Group
COLL icon

Baird Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

Baird Financial Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,279
Closed -$343K – 1697
2023
Q1 		$343K Sell
14,279
-3,525
-20% -$93.5K ﹤0.01% 1450
2022
Q4 		$413K Buy
+17,804
New +$359K ﹤0.01% 1367

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baird Financial Group's COLL Position: Q2 2023 in Review

Baird Financial Group sold out of Collegium Pharmaceutical (COLL) in Q2 2023, closing a stake of 14,279 shares — an estimated $343K sold.

Baird Financial Group first reported a position in COLL in Q4 2022 and held it in 2 quarters. The position peaked at $413K in Q4 2022. 178 funds tracked by Wall St. Rank hold COLL as of Q2 2023.

  • Baird Financial Group reported no remaining Collegium Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Baird Financial Group sold 14,279 Collegium Pharmaceutical shares in Q2 2023, an estimated $343K.
  • Baird Financial Group first reported a position in Collegium Pharmaceutical in Q4 2022 and held it in 2 quarters.
  • Baird Financial Group's Collegium Pharmaceutical position peaked at $413K in Q4 2022.
  • 178 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2023.

Based on Baird Financial Group's 13F filing for Q2 2023, filed 11 Aug 2023.